Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
'Empty promise of law' : Texas Dem says she was denied access to ICE facility
10/07/2025
'Reeks of voter suppression' : Internet slams DOJ demand for state voter list
10/07/2025
WSJ begs Trump to back off mass deportations : 'Economy needs them !'
10/07/2025
'RIP home renovations' : Trump’s massive copper tariff buried in mockery
10/07/2025
GOP lawmaker repeats call to fire Hegseth : 'Embarrassed the president !'
10/07/2025
Trump thumbs nose at Musk with 'tremendous' new NASA pick : 'Fantastic leader !'
10/07/2025
